BAL 2299Alternative Names: BAL2299; Cyclohexanediol - Basilea; RO 65-2299
Latest Information Update: 16 Aug 2006
At a glance
- Originator Basilea Pharmaceutica; Roche
- Class Antipsoriatics; Cyclohexanes; Small molecules
- Mechanism of Action Vitamin D3 stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Psoriasis